These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. [Human gingival immunocompetent cells in the norm and in inflammatory periodontal diseases]. Bykov VL Arkh Patol; 2005; 67(2):51-5. PubMed ID: 15938125 [TBL] [Abstract][Full Text] [Related]
25. [Clinical and histological evaluation of the effect of the Pomorin toothpaste on the gingiva in certain inflammatory periodontal diseases]. Marczak-Wojtyńska A Czas Stomatol; 1970 May; 23(5):615-20. PubMed ID: 4912299 [No Abstract] [Full Text] [Related]
26. [The Muhlemann-Son Sulcus Bleeding Index--its evaluation as a practice-relevant method for early recognition of periodontopathies using comparative measurements of the partial pressure of oxygen in the capillaries of the gingiva]. Krüger KF Stomatol DDR; 1983 May; 33(5):342-8. PubMed ID: 6605601 [No Abstract] [Full Text] [Related]
28. Modulation of gingival epithelial phenotypes by interactions with regionally defined populations of fibroblasts. Locke M; Hyland PL; Irwin CR; Mackenzie IC J Periodontal Res; 2008 Jun; 43(3):279-89. PubMed ID: 18447855 [TBL] [Abstract][Full Text] [Related]
30. [Therapeutic value of Geriocain-Polfa in the treatment of periodontal diseases]. Kozlowski J; Budny J; Kryst L Czas Stomatol; 1967; 20(10):1121-6. PubMed ID: 5235247 [No Abstract] [Full Text] [Related]
31. [Rovamycin concentration in gingiva of patients with hemorrhagic periodontosis after treatment with local drugs]. Atanasova E; Zvetanova M; Klain S Stomatologiia (Sofiia); 1972; 54(2):86-90. PubMed ID: 4513278 [No Abstract] [Full Text] [Related]
32. Local and systemic factors in periodontal disease increase matrix-degrading enzyme activities in rat gingiva: effect of micocycline therapy. Chang KM; Ryan ME; Golub LM; Ramamurthy NS; McNamara TF Res Commun Mol Pathol Pharmacol; 1996 Mar; 91(3):303-18. PubMed ID: 8829770 [TBL] [Abstract][Full Text] [Related]
33. [The use of Soparal in the treatment of the periodontium]. Fisher ND Stomatologiia (Mosk); 1973; 52(5):79. PubMed ID: 4517552 [No Abstract] [Full Text] [Related]
34. [The role of the neuro-vegetative system in the determination of the vascular functional damage in dystrophic periodontal diseases. Clinical and case studies]. Tartaro S; Gombos F Arch Stomatol (Napoli); 1967; 8(3):131-8. PubMed ID: 5246681 [No Abstract] [Full Text] [Related]
37. [A clinical assessment of the value of "para-muc" preparation in the treatment of periodontal disease]. Djukanović D; Sokić G; Popović I; Zajić B; Stanić S Stomatol Glas Srb; 1972; (3):184-9. PubMed ID: 4516902 [No Abstract] [Full Text] [Related]
38. Extracellular glycosaminoglycan changes in healthy and overgrown gingiva fibroblasts after cyclosporin A and cytokine treatments. Stabellini G; Calastrini C; Mariani G; Gioia M; Caramelli E; Gagliano N; Dellavia C; Moscheni C; Vizzotto L; Calvi EM J Oral Pathol Med; 2004 Jul; 33(6):346-53. PubMed ID: 15200483 [TBL] [Abstract][Full Text] [Related]
39. [Topical use of combination drug ointment in acute inflammation of the marginal periodontal diseases]. Marenduzzo A; Valetta G; Gombos F Rev Circ Argent Odontol; 1969 Mar; 32(1):46-8. PubMed ID: 5255000 [No Abstract] [Full Text] [Related]
40. [The regeneration technic, the current practice-related therapy in periodontosis]. Sacher T ZWR; 1974 Apr; 83(8):420-1. PubMed ID: 4527028 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]